Salient Surgical Raises First Round Since Canceling IPO
Salient Surgical Technologies Inc., a Dover, N.H.-based developer of technology for sealing blood vessels and other collagen-based structures, has raised $17.9 million in Series F funding. Arnerich Massena & Associates led the round, and was joined by fellow return backers Medtronic and RiverVest Venture Partners. New investor Piper Jaffray also participated. It is the company’s first new round since canceling an $86.25 million IPO back in August, and brings its total venture capitalization to over $105 million. PRESS RELEASE
29 October 2008•2 mins read
